Back |
home / stock / albo / albo message board
Subject | By | Source | When |
---|---|---|---|
$ALBO up 12%+ on EMA (PRIME) acceptance | djpope | investorshub | 11/15/2016 9:40:36 PM |
We had good news today,it was about the | Inspector Clouseau | investorshub | 11/15/2016 7:58:51 PM |
Thanks I don't have a lot of money | Billthegoat | investorshub | 11/10/2016 9:23:29 PM |
I think somethings up,somebody could be driving the | Inspector Clouseau | investorshub | 11/10/2016 9:18:22 PM |
Hey inspector Give me your thougts | Billthegoat | investorshub | 11/10/2016 9:02:38 PM |
Thank you,Its also a pleasure talking to you.I'll | Inspector Clouseau | investorshub | 11/05/2016 12:34:08 AM |
Nice to talk with you. Let's keep an | Billthegoat | investorshub | 11/04/2016 10:50:40 PM |
I'm holding too,maybe it shoots up in a | Inspector Clouseau | investorshub | 11/04/2016 10:47:44 PM |
If you look it up on etrade there | Inspector Clouseau | investorshub | 11/04/2016 10:40:57 PM |
I agree. Just going to hold for a | Billthegoat | investorshub | 11/04/2016 10:39:18 PM |
I think it may be a good long | Inspector Clouseau | investorshub | 11/04/2016 10:32:45 PM |
Looks like it's going down. Not sure this | Billthegoat | investorshub | 11/04/2016 7:59:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Albireo Pharma Inc. Company Name:
ALBO Stock Symbol:
NASDAQ Market:
Bylvay (odevixibat) granted Priority Review by U.S. FDA ASSERT study demonstrated efficacy of Bylvay in pruritus, bile acids and sleep with a low drug-related diarrhea rate in Alagille patients Approval in second indication would more than double Bylvay market oppo...
NEW YORK, NY / ACCESSWIRE / February 9, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Trean Insurance Group, Inc. (NASDA...
NEW YORK, NY / ACCESSWIRE / February 8, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Oak Street Health, Inc. (NYSE:OSH)'s ...